A61P 19 - Drugs for skeletal disorders

Patents for A61P 19 - Drugs for skeletal disorders (81,981)
11/2006
11/23/2006	US20060264456 Phosphorus-containing compounds & uses thereof
11/23/2006	US20060264443 Treatment of rheumatoid arthritis
11/23/2006	US20060264434 Chemokine receptor binding heterocyclic compounds
11/23/2006	US20060264378 Cxcr4 antagonist and use thereof
11/23/2006	US20060263827 Novel endothelial cells, antibodies directed against said cells and use thereof, in particular for screening angiogenesis inhibiting substances
11/23/2006	US20060263430 instrument for inducing cytokine and method of inducing cytokine
11/23/2006	US20060263422 Pharmaceutical composition containing decoy and use of the same
11/23/2006	US20060263407 Deliver platelet rich plasma, sodium bicarbonate, calcium gluconate, choline chloride buffers, thrombin, collagen, epinephrine releasate, via catheter; stent implants
11/23/2006	DE20221674U1 Composition useful as a food or food supplement, and for treating e.g. tumors or osteoporosis, contains isoflavone, lignan and phytosterol
11/23/2006	CA2608957A1 Pyrrolidine derivative or salt thereof
11/23/2006	CA2607472A1 Antipyretic agents against vr1-antagonist-induced increases in body temperature
11/22/2006	EP1724287A1 Hyaluronic acid/methotrexate compound
11/22/2006	EP1724286A1 Variant CD44 polypeptide, polynucleotides encoding same, antibodies directed there against and method of using same for diagnosing and treating inflammatory diseases
11/22/2006	EP1724278A1 Nitrogenous fused-ring derivatives, medicinal compositions containing the derivatives, and use thereof as drugs
11/22/2006	EP1724277A1 Fused heterocycle derivative, medicinal composition containing the same, and medicinal use thereof
11/22/2006	EP1724270A2 Phenylacetamido-thiazole derivatives, process for their preparation and their use as antitumor agents
11/22/2006	EP1724267A1 Pyrimidine derivative
11/22/2006	EP1724264A1 Nitriles and medicinal compositions containing the same as the active ingredient
11/22/2006	EP1724257A1 Medicinal composition for prevention or treatment of overactive bladder accompanying nervous disorder
11/22/2006	EP1723961A2 Pharmaceutical composition comprising at least one bone morphogenetic protein (BMP)
11/22/2006	EP1723959A1 Composition comprising platelet-rich plasma
11/22/2006	EP1723954A1 Indazole derivatives for the treatment of cancer
11/22/2006	EP1723157A1 Amorphous forms of risedronate monosodium
11/22/2006	EP1723148A2 Thieno-imino acid derivatives for use as matrix metalloproteinase inhibitors
11/22/2006	EP1723105A1 Bicyclic substituted indole-derivative steroid hormone nuclear receptor modulators
11/22/2006	EP1722856A1 Use of 2-methylene-19-nor-20(s)-1alpha,25-dihydroxyvitamin d3 for the prophylaxis of bone diseases
11/22/2006	EP1722810A1 Combination of morphogenic proteins having tissue inductive properties
11/22/2006	EP1722793A1 Bicyclic modulators of androgen receptor function
11/22/2006	EP1722790A2 Novel bicyclic compounds as modulators of androgen receptor function and method
11/22/2006	EP1534265B1 Combination of an aromatase inhibitor with a bisphosphonate
11/22/2006	EP1467982B1 Glucocorticoid mimetics, methods of making them, pharmaceutical formulations containing them, and uses thereof
11/22/2006	EP1458721B1 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino [4,5-b]indole-1-carboxamide derivatives, their preparation and therapeutic use
11/22/2006	EP1360186B1 Carboline derivatives
11/22/2006	EP1351933B1 Il-8 receptor antagonists
11/22/2006	EP1317450B1 Pyrazole compounds useful as protein kinase inhibitors
11/22/2006	EP1315482B1 Water-dispersible encapsulated sterols
11/22/2006	EP1220682B1 Stabilized liquid polypeptide-containing pharmaceutical compositions
11/22/2006	EP1120114B1 Compositions and methods for treating conditions responsive to estrogen
11/22/2006	EP1096924B1 Inhibitors of proteasomal activity for stimulating hair growth
11/22/2006	EP1078054B1 Monomeric mp52/gdf-5 with bone morphogenetic activity and medicinal agent containing the same for preventing and treating diseases of cartilage and bone
11/22/2006	EP1051395B1 N-hydroxyformamide derivatives
11/22/2006	EP1051176B1 SUBSTITUTED OXOAZAHETEROCYCLYL FACTOR Xa INHIBITORS
11/22/2006	EP0942925B1 Inhibitors of interleukin-1 beta converting enzyme
11/22/2006	EP0939821B1 G-beta-gamma regulated phosphatidylinositol-3' kinase
11/22/2006	CN1867560A 4-pyrimidone derivatives and their use as peptidyl peptidase inhibitors
11/22/2006	CN1865270A Fructose-1,6-diphosphate calcium preparation and uses
11/22/2006	CN1865248A Imidazole-4-carboxamide derivatives, preparation and use thereof for treatment of obesity
11/22/2006	CN1864735A A Chinese medicine for treating hyperosteogeny and preparation method thereof
11/22/2006	CN1864729A A wound healing pure Chinese medicine
11/22/2006	CN1864722A A pharmaceutical composition for treating muscles and bones pain and lumbar intervertebral disc protrusion
11/22/2006	CN1864721A Chinese medicinal wine
11/22/2006	CN1864710A A medicine for treating osteoporosis
11/22/2006	CN1864704A Herbal composition for treatment of arthritic disorders, skin inflammatory disorders and pain
11/22/2006	CN1864662A A triptolide composite preparation for treating osteoarthritis by joint intracavity injection
11/22/2006	CN1285580C Pyrimidine compounds
11/22/2006	CN1285578C Substituted benzoic acid amides and use for inhibition of angiogenesis thereof
11/22/2006	CN1285573C 3-desoxy-vitamin D3 analog esters
11/22/2006	CN1285572C Cannabinod receptor ligands
11/22/2006	CN1285342C Simple prescription of earthworm oral liquid for treating alveolar bone resorption and its preparing method
11/21/2006	US7138543 Thiolalkyl benzoic acid derivatives
11/21/2006	US7138530 for inhibiting the enzyme C1s, a protease in the classical pathway of the complement system; and the use of this inhibition to treat or ameliorate acute or chronic disorders in mammals
11/21/2006	US7138432 Arylsulfonamido-substituted hydroxamic acid derivatives
11/21/2006	US7138430 Nitrosated and nitrosylated nebivolol and its metabolites, compositions and methods of use
11/21/2006	US7138426 Estrogen receptor modulators
11/21/2006	US7138424 Indole derivatives, method for preparing same and pharmaceutical compositions containing same
11/21/2006	US7138417 Inhibitors of integrin αvβ6
11/21/2006	US7138416 Compounds and therapeutic uses thereof
11/21/2006	US7138413 Administering tertiary amines, e.g., 3,3-Dimethylbutyl 3-piperidinopropyl ether, 3-Phenylpropyl 3-piperidinopropyl ether, or3-(4-Chlorophenyl)propyl 3-piperidinopropyl ether to treat cognitive disorders such as attention, wakefulness and memory disorders
11/21/2006	US7138411 Substituted benzopyran derivatives for the treatment of inflammation
11/21/2006	US7138404 Anxiolytic agents and analgesics
11/21/2006	US7138403 2,4,5-trisubstituted thiazolyl derivatives and their antiinflammatory activity
11/21/2006	US7138402 Pyrrolopyrimidines and related analogs as HSP90-inhibitors
11/21/2006	US7138399 2-[2-(4-alkoxypyridin-2-yl)alkyl])-3H-imidazo[4,5-b]pyridine derivatives and 8-[2-(4-alkoxypyridin-2-yl)alkyl])-9H-purine derivatives; used to treat an acute inflammatory disease in which the activity of inducible NO-synthase is involved
11/21/2006	US7138392 1-[4-(2-Azepan-1-yl-ethoxy)-benzyl-2-(4-hydroxy-phenyl])-3-methyl-1H-indol-5-ol, or salts for treating bone loss
11/21/2006	US7138386 Preventives or remedies for arthritis
11/21/2006	US7138371 Remodeling and glycoconjugation of peptides
11/21/2006	US7138370 Anticancer agents; skin disorders; antiinflamamtory agents; antiarthritic agents
11/21/2006	US7137989 Method, instruments, and kit for autologous transplantation
11/21/2006	CA2334843C Diarylselenide compounds and their use in human or veterinary medicine and in cosmetics
11/21/2006	CA2334718C Quinoline derivatives
11/21/2006	CA2247257C Novel aryl glycinamide derivatives, method of producing said derivatives and pharmaceutical compositions containing these compounds
11/18/2006	CA2547251A1 Fused pyrazolyl compounds for cancer treatment
11/16/2006	WO2006122137A1 1, 6 -dihydro- 1,3, 5, 6-tetraaza-as-indacene based tricyclic compounds and pharmaceutical compositions comprising same as inhibitors of ikk enzyme activity
11/16/2006	WO2006121095A1 Substituted acrylamide derivative and pharmaceutical composition comprising the same
11/16/2006	WO2006120974A1 Health food and pharmaceutical composition for amelioration of disease induced by metabolic disorder in cartilage
11/16/2006	WO2006119965A2 Growth factor mutants with altered biological attributes
11/16/2006	US20060258839 Cardiovascular disorders; antiinflammatory agents; resemble a G amphipathic helix of apolipoprotein J; phospholipids
11/16/2006	US20060258726 1,5-Disubstituted imidazolidin-2-one derivatives for use as ep4 receptor agonists in the treatment of eye and bone diseases
11/16/2006	US20060258724 Anticoagulants; cardiovascular disorders; atherosclerosis; antiarthritic agents; Alzheimer's disease; anticancer agents
11/16/2006	US20060258700 7-azaindoles, their use as inhibitors of phosphodiesterase 4, and a method for synthesizing them
11/16/2006	US20060258661 N-(pyridin-2-ylmethyl)-4-methyl-3-oxo-4-aza-5 alpha -androst-1-en-17 beta -acetamide; enhancement of weakened muscle tone; osteoporosis, bone disorders; ; periodontal disease, frailty, aging skin, male hypogonadism, postmenopausal symptoms, inflammatory arthritis, cachexia, Alzheimer's disease
11/16/2006	US20060258658 Triazole compounds useful as protein kinase inhibitors
11/16/2006	US20060258650 Phenothiazine enantiomers as agents for the prevention of bone loss
11/16/2006	US20060258588 Compositions and methods for treating articular cartilage disorders
11/16/2006	US20060257989 Truncated aggrecanase molecules
11/16/2006	US20060257965 Extracellular matrix signalling molecules
11/16/2006	US20060257911 Of given nucleotide sequence; diagnosis, treatment, and prevention of cell proliferative, neurological, cardiovascular, gastrointestinal, autoimmune/inflammatory, and metabolic disorders
11/16/2006	US20060257882 Novel polynuceotides and polypeptides encoded thereby
11/16/2006	US20060257427 Molecule (antibody, peptide or chemical), coupled to a detectable label, cytotoxic agent or solid support, that specifically binds an extracellular portion of the latent viral membrane bound protein of Epstein-Barr Virus expressed in the latent viral membrane in the latent life cycle
11/16/2006	US20060257392 Remedy or preventive for low turnover bone diseases

1 ... 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 403 404 ... 820